Inhibition of goiter growth and of cyclic AMP formation in rat thyroid by 2-iodohexadecanal

Molecular and Cellular Endocrinology

Volumn 317, Issue 1-2, 2010, Pages 141-147

  Thomasz, L ^a   Oglio, R ^a   Rivandeira, D Toro ^a   Dagrosa, M A ^a   Jahn, G ^b   Piganataro, O P ^b   Sartorio, G ^a   Pisarev, M A ^a,c   Juvenal, G J ^a  

^a DEPARTAMENTO DE FÍSICA   (Argentina)

^b Larlac ^*  (Argentina)

^c F de Medicina UBA   (Argentina)

Author keywords

Antigoitrogenics; Iodolipids; Thyroid

Indexed keywords

2 IODOHEXADECANAL; AMINOTRANSFERASE; ANTITHYROID AGENT; CHOLESTEROL; CREATININE; CYCLIC AMP; CYCLINE; CYTOKINE; INTERLEUKIN DELTA; IODIDE; LIOTHYRONINE; THIAMAZOLE; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG; UREA;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGOITROGENIC ACTIVITY; ARTICLE; CELL COUNT; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG SYNTHESIS; EPITHELIUM; FEMALE; GOITER; GROWTH INHIBITION; IN VITRO STUDY; INVOLUTION; LIOTHYRONINE BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID WEIGHT; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION; UREA BLOOD LEVEL;

ALDEHYDES; ANIMALS; CYCLIC AMP; GOITER; METHIMAZOLE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 74749094233     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.12.026     Document Type: Article

References (39)

1. Berthier C., and Lemarchand-Beraud T. Importance of the thyroid iodine, cyclicAMP and TSH concentration in goiter formation in rats. Acta Endocrinol. (Copenh.) 89 (1978) 567-579
2. Boeynaems J.M., and Hubbard W.C. Transformation of arachidonic acid into an iodolactone by the rat thyroid. J. Biol. Chem. 255 (1980) 9001-9004
3. Bray G.A. Increased sensitivity of the thyroid in iodine-depleted rats to the goitrogenic effects of thyrotropin. J. Clin. Invest. 47 (1968) 1640-1647
4. Chazenbalk G.D., Valsecchi R.M., Krawiec L., Burton G., Juvenal G.J., Monteagudo E., Chester H.A., and Pisarev M.A. Thyroid autoregulation. Inhibitory effects of iodinated derivatives of arachidonic acid on iodine metabolism. Prostaglandins 36 (1988) 163-172
5. Del Punta K., Charreau E.H., and Pignataro O.P. Nitric oxide inhibits Leydig cell steroidogenesis. Endocrinology 137 (1996) 5337-5343
6. Dugrillon A., Bechtner G., Uedelhoven W.M., Weber P.C., and Gartner R. Evidence that an iodolactone mediates the inhibitory effect of iodide on thyroid cell proliferation but not on adenosine 3′,5′-monophosphate formation. Endocrinology 127 (1990) 337-343
7. Dugrillon A., and Gartner R. delta-Iodolactones decrease epidermal growth factor-induced proliferation and inositol-1,4,5-trisphosphate generation in porcine thyroid follicles-a possible mechanism of growth inhibition by iodide. Eur. J. Endocrinol. 132 (1995) 735-743
8. Dugrillon A., Uedelhoven W.M., Pisarev M.A., Bechtner G., and Gartner R. Identification of delta-iodolactone in iodide treated human goiter and its inhibitory effect on proliferation of human thyroid follicles. Horm. Metab. Res. 26 (1994) 465-469
9. Dumont J.E., Lamy F., Roger P., and Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol. Rev. 72 (1992) 667-697
10. Eggo M.C. Angiogenesis in goitrogenesis. Curr. Opin. Endocrinol. Diab. 10 (2003) 341-346
11. Gérard A.-C., Poncin S., Audinot J.-N., Denef J.-F., and Colin I.M. Iodide deficiency-induced angiogenic stimulus in the thyroid occurs via HIF- and ROS-dependent VEGF-A secretion from thyrocytes. Am. J. Physiol. Endocrinol. Metab. 296 (2009) E1414-E1422
12. Gérard A.-C., Poncin S., Caetano B., Sonveaux P., Audinot J.-N., Feron O., Colin I.M., and Soncin F. Iodine deficiency induces a thyroid stimulating hormone-independent early phase of microvascular reshaping in the thyroid. Am. J. Pathol. 172 (2008) 748-760
13. Juvenal G.J., Pisarev M., Kleiman de Pisarev D., and Altschuler N. Uptake, metabolism and action of triiodothyronine in calf thyroid slices. Mol. Cell. Endocrinol. 22 (1981) 31-40
14. Kero J., Ahmed K., Wettschureck N., Tunaru S., Wintermante T., Greiner E., Schütz G., and Offermanns S. Thyrocyte-specific Gq/G11 deficiency impairs thyroid function and prevents goiter development. J. Clin. Invest. 117 (2007) 2399-2407
15. 2 availability. Horm. Metab. Res. 20 (1988) 86-90
16. Lissitzky S., Gregoire J., Gregoire J., and Limozin N. The presence and in vitro activity of free iodinated peptides in the thyroid gland of mammals and man. Gen. Comp. Endocrinol. 1 (1961) 519-533
17. Many M.C., Denef J.-F., and Haumont S. Precocity of the endothelial proliferation during a course of rapid goitrogenesis. Acta Endocrinol. (Copenh.) 105 (1984) 487-491
18. Many M.C., Denef J.F., Haumont S., van den Hove-Vandenbroucke M.F., Cornette C., and Beckers C. Morphological and functional changes during thyroid hyperplasia and involution in C3H mice: effects of iodine and 3,5,3′-triiodothyronine during involution. Endocrinology 116 (1985) 798-806
19. Matsuzaki S., Kakegawa T., and Hamana K. Thyroid function and polyamines contents in the rat thyroid during hyperplasia and involution. Endocrinol. Jpn. 25 (1978) 129-139
20. Michalkiewicz M., Huffman L.J., Connors J.M., and Hedge G.A. Alterations in thyroid blood flow induced by varying levels of iodine intake in the rat. Endocrinology 125 (1989) 54-60
21. Mutaku J.F., Poma J.F., Many M.C., Denef J.-F., and van den Hove M.F. Cell necrosis and apoptosis are differentially regulated during goitre development and iodine-induced involution. Eur. J. Endocrinol. 172 (2002) 275-386
22. Ohayon R., Boeynaems J.M., Braekman J.C., Van den Bergen H., Gorin Y., and Virion A. Inhibition of thyroid NADPH-oxidase by 2-iodohexadecanal in a cell-free system. Mol. Cell. Endocrinol. 99 (1994) 133-141
23. 2 production by iodoaldehydes in cultured dog thyroid cells. Mol. Cell. Endocrinol. 102 (1994) 167-176
24. Panneels V., Van Sande J., Van den Bergen H., Jacoby C., Braekman J.C., Dumont J.E., and Boeynaems J.M. Inhibition of human thyroid adenylyl cyclase by 2-iodoaldehydes. Mol. Cell. Endocrinol. 106 (1994) 41-50
25. Panneels V., Macours P., Van den Bergen H., Braekman J.C., Van Sande J., and Boeynaems J.M. Biosynthesis and metabolism of 2-iodohexadecanal in cultured dog thyroid cells. J. Biol. Chem. 271 (1996) 23006-23014
26. Panneels V., Juvenal G., Boeynaems J.M., Dumont J.E., and Van Sande J. Iodide effects on the thyroid. In: Preedy V.R., Burrow G.N., and Watson R. (Eds). Comprehensive Handbook on Iodine: Nutritional, Endocrine and Pathological Aspects (2009), Oxford Academic Press 99305-99316
27. Patel V.A., Hill D.J., Sheppard M.C., Wang J.F., Logan A., and Eggo M.C. Apoptosis during goitre involution-the role of Bcl-2. J. Endocrinol. 164 (2000) 323-330
28. Pereira A., Braekman J.C., Dumont J.E., and Boeynaems J.M. Identification of a major iodolipid from the horse thyroid gland as 2-iodohexadecanal. J. Biol. Chem. 265 (1990) 17018-17025
29. Pisarev M.A., Chazenbalk G.D., Valsecchi R.M., Burton G., Krawiec L., Monteagudo E., Juvenal G.J., Boado R.J., and Chester H.A. Thyroid autoregulation. Inhibition of goiter growth and of cyclic AMP formation in rat thyroid by iodinated derivatives of arachidonic acid. J. Endocrinol. Inv. 11 (1988) 669-674
30. Pisarev M.A., and Gartner R. Autoregulatory action of iodine. In: Braverman L.E., and Uitger R.D. (Eds). The Thyroid. 9th ed. (2000), Lippincott, Philadelphia 85-90
31. Pisarev M.A., and Itoiz M.E. Action of KI on stimulated thyroid protein biosynthesis. Endocrinology 90 (1972) 1409-1412
32. Pisarev M.A., Krawiec L., Juvenal G.J., Bocanera L., Pregliasco ., Sartorio L., and Chester G.H. Studies on the goiter inhibiting action of iodolactones. Eur. J. Pharmacol. 258 (1994) 33-37
33. Pisarev M.A., Utiger R.D., Salvaneschi J.P., Altschuler N., and De Groot L.J. Serum TSH and thyroxine in goitrous subjects in Argentina. J. Clin. Endocrinol. Metab. 30 (1970) 680-681
34. Poncin S., Gérard A.-C., Boucquey M., Senou M., Buc Calderon P., Knoops B., Lengelé B., Many M.C., and Colin I.M. Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. Endocrinology 149 (2008) 424-433
35. Ramsden J.D., Buchanan M.A., Egginton S., Watkinson J.C., Mautner V., and Eggo M.C. Complete inhibition of goiter in mice requires combined gene therapy modification of angiopoietin, vascular endothelial growth factor, and fibroblast growth factor signaling. Endocrinology 146 (2005) 2895-2902
36. Rognoni J.B., Penel C., Golstein J., Galand P., and Dumont J.E. Cell kinetics of thyroid epithelial cells during hyperplastic goitre involution. J. Endocrinol. 114 (1987) 483-490
37. Steiner A.L., Kipnis D.M., Utiger R., and Parker C. Radioimmunoassay for the measurement of adenosine 3′, 5′-cyclic phosphate. Proc. Natl. Acad. Sci. USA 64 (1969) 367-373
38. Van Sande J., Grenier G., Willems C., and Dumont J.E. Inhibition by iodide of the activation of the thyroid cyclic 3′,5′-AMP system. Endocrinology 96 (1975) 781-786
39. Yamada E., Yamazaki K., Takano K., Obara T., and Sato K. Iodide inhibits vascular endothelial growth factor-A expression in cultured human thyroid follicles: a microarray search for effects of thyrotropin and iodide on angiogenesis factors. Thyroid 16 (2006) 545-554